Regenerative Plastic Surgery


Series: Plastic and Reconstructive Surgery
BISAC: MED085030
DOI: 10.52305/PHUS6579

Regenerating damaged organs and tissues, an act that once was considered magic is currently entrusted to the surgeons who have allowed us to move from replacement and reconstructive plastic surgery to regenerative plastic surgery, through autologous and allogeneic cell-based therapies and growth factors.
The enthusiasm for regenerative plastic surgery and for the treatment of some pathologies addressed by it, such as breast reconstruction, hemifacial atrophy, burns, scars, and aesthetic improvements such as breast and buttock augmentation, face rejuvenation and hair regrowth, has led the author, Professor Pietro Gentile, to rigorously investigate the possible new minimally invasive strategies based on adipose-derived stem cells, human follicle stem cells and growth factors contained in platelet-rich plasma.
This book reports on the latest knowledge regarding the treatment of soft and bone tissue defects.
Therefore, the goal of this text is to introduce and definitively establish this new and interesting field of plastic surgery, called regenerative plastic surgery.

Table of Contents

Table of Contents



Chapter 1. Application of Platelet-Rich Plasma (PRP) in Regenerative Plastic Surgery

Chapter 2. Application of Fat Graft in Regenerative Plastic Surgery

Chapter 3. Autologous Platelet-Rich Plasma (A-PRP): Clinical Use of Activated or Not-Activated A-PRP in Androgenetic Alopecia (AGA)

Chapter 4. Clinical Use of Autologous Human Adipose Tissue-Derived Hair Follicle Stem Cells (HAD-HFSCS) in Androgenetic Alopecia

Chapter 5. Clinical Use of Autologous Fluid Cartilage as Biomaterial in the Treatment of Minor Nose Defects

Chapter 6. Gluteal Augmentation Using Autologous Fat Grafting

Chapter 7. Application of Fat Graft Enhanced with Platelet-Rich Plasma and/or Adipose-Derived Stem Cells in Outcomes of Scars

Chapter 8. Biomaterials, Growth Factors and Stem Cell Therapy in Wound Healing

Chapter 9. Stromal Vascular Fraction (SVF) and Adipose-Derived Mesenchymal Stem Cells (AD-MSCS) as a Potential, Safe and Effective Therapy in Combating Coronavirus Disease 2019 (COVID-19)

Chapter 10. FDA and European Rules Regarding Use of Adipose Derived-Stem Cells (ASCS), Human Follicle Mesenchymal Stem Cells (HF-MSCS) and Platelet-Rich Plasma (PRP) in Regenerative Plastic Surgery


Additional information



Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!